about
Malignant solitary fibrous tumor with high-grade nuclear atypia: an alternate entity for the undetermined tumor group.Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomasPhysical performance deterioration of temporary housing residents after the Great East Japan EarthquakeExpression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.Point mutations in an epigenetic factor lead to multiple types of bone tumors: role of H3.3 histone variant in bone development and disease.Histological spectrum of angiofibroma of soft tissue: histological and genetic analysis of 13 cases.Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.Living in Contaminated Radioactive Areas Is Not an Acute Risk Factor for Noncommunicable Disease Development: A Retrospective Observational Study.Detection of 131I in a patient with thyroid cancer by internal radiation exposure screening using a whole-body counter in Fukushima.Epithelial and cartilaginous differentiation in clear cell chondrosarcoma.A report from Fukushima: an assessment of bone health in an area affected by the Fukushima nuclear plant incident.Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma.Detecting residual fluorine 18 from a medical PET-CT procedure during population whole body counter screening in Fukushima.Osteogenic differentiation in dedifferentiated liposarcoma: a study of 36 cases in comparison to the cases without ossification.Cancer-testis antigens are predominantly expressed in uterine leiomyosarcoma compared with non-uterine leiomyosarcoma.Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genes.Ossifying fibromyxoid tumor presenting EP400-PHF1 fusion gene.Phosphorylation of STAT3 in Undifferentiated Pleomorphic Sarcoma Is Correlated with a Favorable Prognosis.Soft tissue sarcomas: From a morphological to a molecular biological approach.Conventional spindle cell-type malignant peripheral nerve sheath tumor arising in a sporadic schwannoma.MAGEA4 expression in bone and soft tissue tumors: its utility as a target for immunotherapy and diagnostic marker combined with NY-ESO-1.Leiomyosarcoma in the humerus with leukocytosis and elevation of serum G-CSFDrowningFibrocartilaginous mesenchymoma arising in the pubic bone: a case reportActivation of the Akt/mammalian target of rapamycin pathway in myxofibrosarcomas
P50
Q33419575-F97C30BA-2635-4BF7-BEF7-F61A7F099CEFQ36083264-65FF31D7-AB54-4A98-8E0C-77906A9EBDE5Q36486677-430EC139-A197-4EBF-96B9-75943BDF2256Q36495922-9F67C2E4-D21B-4582-BA24-9C2411439D51Q37082518-82CD39EC-90BB-445E-9EE7-F643D4879E59Q38544292-06D536AA-548F-4B58-9AC5-A6831D585D48Q38723165-EE44CD5A-8710-4724-81C1-8AB3F0DDEA4AQ38759407-824F5D6D-7111-4E0B-B9ED-51C6AD02C5B1Q38823442-299694E1-D20B-4418-B17B-405F0AA049C1Q39087077-6A7245A4-55D8-4B28-AB4F-BCAA8CDFBB4FQ39233063-6898A88C-59B3-4037-9D9E-A925CDD047FAQ40562694-A7765B31-59FA-4347-B1C4-4882A05B4542Q41964988-6F4A6B8B-9714-41C4-97B2-8BA6BF18724FQ44263780-D6C5B29E-D270-4145-AFC0-22D88F4EBFFAQ45201243-CBE6FADF-7E11-4476-89D8-73D667A0BCA0Q47994466-C1D25F7F-9916-42E4-BE30-30BD2F43E4CCQ48041236-F1C38775-6681-4298-BEE4-59F8B9499B39Q48116296-A791A30D-4DF6-4A50-A82F-682F08665C4EQ49335269-0A6C4A14-F09B-4CF7-94D9-E04D166BA626Q50216130-E67615B1-ED8F-4B74-9AA3-3A65F7D3924FQ50873323-A1F4776C-678F-4841-A96B-089280B49557Q51480207-0B8F873F-2C2B-4DA5-A88C-6936E3478D9AQ51817033-7C72BC31-7FE7-4613-917A-EE5C30F5A6D0Q53249734-617247E5-84CE-46D3-BC70-8C13B9A0A050Q54489272-4DD54ADC-3BC0-4DDE-9E98-428994F19934Q82943289-64A4BE93-1464-401B-BEB9-870BD72A8C9CQ84850441-EE42C30F-A670-47AC-BCFB-79D100DA127FQ86834348-21BEB05B-3EA7-436D-97D3-364230D000DBQ87709974-A33ADB61-F585-47C4-9165-52A784960AC0
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Takeaki Ishii
@ast
Takeaki Ishii
@en
Takeaki Ishii
@es
Takeaki Ishii
@nl
type
label
Takeaki Ishii
@ast
Takeaki Ishii
@en
Takeaki Ishii
@es
Takeaki Ishii
@nl
prefLabel
Takeaki Ishii
@ast
Takeaki Ishii
@en
Takeaki Ishii
@es
Takeaki Ishii
@nl
P31
P496
0000-0003-0131-205X